Clinical Trials
2 trialsNCT01171898 2026-05-11
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Aragon Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT04402008 2024-06-25
Study of Poziotinib in Japanese Patients With NSCLC
Spectrum Pharmaceuticals, Inc
Phase 1/2 Terminated